Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 9
2005 7
2006 2
2007 5
2008 3
2009 5
2010 6
2011 9
2012 6
2013 5
2014 7
2015 11
2016 8
2017 8
2018 6
2019 4
2020 7
2021 3
2022 3
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
DNA damage checkpoint kinases in cancer.
Smith HL, Southgate H, Tweddle DA, Curtin NJ. Smith HL, et al. Among authors: curtin nj. Expert Rev Mol Med. 2020 Jun 8;22:e2. doi: 10.1017/erm.2020.3. Expert Rev Mol Med. 2020. PMID: 32508294 Review.
Targeting the ATR-CHK1 Axis in Cancer Therapy.
Rundle S, Bradbury A, Drew Y, Curtin NJ. Rundle S, et al. Among authors: curtin nj. Cancers (Basel). 2017 Apr 27;9(5):41. doi: 10.3390/cancers9050041. Cancers (Basel). 2017. PMID: 28448462 Free PMC article. Review.
Warburg and Krebs and related effects in cancer.
Unterlass JE, Curtin NJ. Unterlass JE, et al. Among authors: curtin nj. Expert Rev Mol Med. 2019 Sep 27;21:e4. doi: 10.1017/erm.2019.4. Expert Rev Mol Med. 2019. PMID: 31558177 Review.
Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma.
Vormoor B, Curtin NJ. Vormoor B, et al. Among authors: curtin nj. Curr Opin Oncol. 2014 Jul;26(4):428-33. doi: 10.1097/CCO.0000000000000091. Curr Opin Oncol. 2014. PMID: 24840521 Free PMC article. Review.
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C. Berger NA, et al. Among authors: curtin nj. Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.
107 results